Search Results - "Roy, Nand K"
-
1
Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far
Published in Recent patents on anti-cancer drug discovery (01-02-2016)“…Research over the past several years has developed many mono-targeted therapies for the prevention and treatment of cancer, but it still remains one of the…”
Get more information
Journal Article -
2
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers
Published in Nature communications (11-01-2022)“…B cell-activating factor (BAFF) binds the three receptors BAFF-R, BCMA, and TACI, predominantly expressed on mature B cells. Almost all B cell cancers are…”
Get full text
Journal Article -
3
Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases
Published in Frontiers in pharmacology (06-08-2018)“…Extensive research during last 2 decades has revealed that most drugs discovered today, although costs billions of dollars for discovery, and yet they are…”
Get full text
Journal Article -
4
Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy
Published in Frontiers in pharmacology (30-08-2022)Get full text
Journal Article -
5
NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells
Published in Frontiers in immunology (29-04-2021)“…Natural Killer (NK) cells are cytotoxic lymphocytes critical to the innate immune system. We found that germline deficiency of NF-κB c-Rel results in a marked…”
Get full text
Journal Article -
6
BAFF receptor antibody for mantle cell lymphoma therapy
Published in Oncoimmunology (01-01-2021)“…Mantle cell lymphoma (MCL) is an aggressive form of B cell non-Hodgkin's lymphoma and remains incurable under current treatment modalities. One of the main…”
Get full text
Journal Article